Hydroxyapatite labelled with yttrium-90 or lutetium 177 for radiation synovectomy Online publication date: Mon, 18-Jan-2010
by Renata Martinussi Couto, Adriano Aparecido De Souza, Rosana Herrerias, Emiko Muramoto, Jair Mengatti, Marycel Figols De Barboza, Elaine Bortoleti De Araujo
Atoms for Peace: an International Journal (AFP), Vol. 3, No. 1, 2010
Abstract: Radiation Synovectomy (radiosynovectomy, radiosynoviorthesis or RSV) is a method of treatment by intra-articular application of beta-emitting radioisotopes. There are several radionuclides available for this treatment and some radiopharmaceuticals have been shown to be effective and safe for this procedure. Hydroxyapatite (HA) particles are regarded as one of the most suitable carriers for applications in RSV, and labelling with 177Lu or 90Y has been investigated. Owing to their favourable decay characteristics, 177Lu Lu has been used in RSV of small-sized joints and 90Y has been the most useful radionuclide for applications in knee joints. The present work describes the preparation, labelling and quality control of HA using both radionuclides. The labelling yield is higher than 87.0%. The final product presents a radiochemical purity >98.9%, with the particle range >12 μm and a stability of 5 days at room temperature. A scintigraphic investigation by gamma camera was performed in rats to evaluate the extra-articular leakage from the knee. Both preparations appeared suitable for RSV with no extra-articular leakage and no acute complication in the clinical study using 90Y-HA.
Online publication date: Mon, 18-Jan-2010
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the Atoms for Peace: an International Journal (AFP):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email email@example.com